There is a small amount of borrow available to allow you to short Standard Listed Supply@ME Capital (SYME) and after this week you should, if you can, grab it with the shares at 0.44p. The market cap is still well over £100 million and this is a zero in waiting…

Share in AIM-listed jam-tomorrow investment company Tern plc (TERN) ended last week at 7.7p – a 10% premium to the last stated net asset value per share of 7p. It was a better week, having seen the share price hit a low point of just 6.25p at the beginning of September. Of Tern’s net assets of £20.1 million at the interim stage, its principal investee Device Authority (DA) accounts for £13.8 million – or 68.7% and last week DA’s accounts appeared at Companies House. Oh dear……

Last month I wrote about the insurance and travel name Saga (SAGA) and its announced money raising, with money being tapped from the new non-executive chair (at a premium!) as well as existing shareholders and the market. At the link, I called it ‘ten out of ten for commitment’ and on Friday we had the results of the money raising…

Welcome to the Sunday ShareProphets Pub Quiz. Find your own beer, sit in the most comfortable seat, and, under no circumstances, can you Google the answer. Only I can do that. There are no prizes but post your scores in the comments for bouquets and brickbats.

Here are five long reads that have nothing to do with shares. Put the kettle on, find a comfy chair. You have the time, don’t you?

The most read non-Tom article this week, Centamin – Movement in Stage 4 West wall leads to suspension of open pit operations there: Buying Opportunity by Nigel Somerville, is at a terrific number two or at number four, including Bearcasts and Tom’s new shareshow. Which one is the best of the week? Tell me in the comments.

It has been some time since there has been a really big exploration drill for an AIM listed company, but that is exactly what should be coming soon for Bahamas Petroleum (BPC).

Even sir Isaac got his trading badly wrong

On 30 September 2020, Iconic Labs (ICON) announced a Partnership with leading Ad-tech tech provider with the first paragraph stating “Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business, today announces that after a successful trial Iconic Labs has signed a commercial partnership agreement with Glimpse Protocol, a leading provider of advanced technologies to Ad-tech.”

I start with a personal message as to why there may or may not be a break in bearcasts over the next few days. Then it is onto how Watchstone (WTG) – Quenron (QPP) as was – is suing KPMG. This is bonkers. KPMG has made Watchstone shareholders far richer than they should be. I explain that and then discuss how if I was in charge and had a time machine, we would have stopped this fraud ever happening. Without the time machine, what would I do now? 

OptiBiotix Health (OPTI) is “pleased to see that Seed has achieved FDA authorisation for an IND in a product containing OptiBiotix’s Lactobacillus plantarum LP_LDL^®”. So, what does this mean?…

This is my sort of bird! Danielle DiMartino Booth is the CEO and Chief Strategists for Quill Intelligence, a research and analytics firm. She makes a stark warning about the USA and the dollar.

Last week’s interim results for Yu Group (YU.) show net assets of £3,753,000 but this includes £4,730,000 of a deferred tax asset. Without this asset, the group would be technically insolvent as liabilities would exceed assets.

From the FCA’s spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2019 and thus far in 2020 (by net short position %, those in bold not on the list at the start of 2020) – and if this position has increased (red), reduced (green) or remained unchanged (black) since last week…

Hello, Share Pickers. Should you hate making big decisions, share pricking is not for you. A fairly frequent armchair trader has to make them all the time. It’s not just a question of whether we should dump a share, hold or buy more. There’s the more pertinent issue of timing, either long-term or at what part of the day to hit the buy or sell button. I suspect most of us are dithery decision-makers.

OptiBiotix (OPTI) has announced that it is “pleased to have signed an agreement with UITC to distribute our award-winning medical device in Singapore”…

It is not quite in the league of that from Scancell (SCLP) but sub scale investment tidder Pires Investments (PIRI) is also clambering aboard the Covid bandwagon.

I pray that Donald Trump and the fragrant Melania recover from Covid and, unlike godless liberals who tweet about praying for things, I do actually pray and to someone I believe in. However, Lucian has a bet on Mike Pence to be the next President and I discuss this. I then move on to look at UK Oil & Gas (UKOG) where I did tell y’all, Attis Oil & Gas (AOGL) and share rampers from the AIM swamps, Purplebricks (PURP), and also the latest mystery at Supply@ME Capital (SYME), the worthless POS from the province of Norfolk. Later I am recording a video that I am sure many of you will enjoy.

Oh dear – this is not what the doctor ordered at all. Fully-listed Centamin (CEY) has announced the suspension of open pit operations at the Stage 4 West Wall of its Sukari gold mine. This follows the detection of movement in a localised area of waste material and production for Q4 will be heavily reduced to around 70,000 oz. But is it the disaster it first appears?

I have documented over many years what a rotten investment Scancell (SCLP) has been but its spoofing on its quest for a Covid vaccine is one of the biggest red flags fluttering. Today it plunged new depths of spoofery as it announced a collaboration with Cobra Biologics “for Cobra to manufacture Scancell’s COVID-19 vaccine.” Great, except that…